Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Jabak Visited the Mais al-Jabal, Tebnine and Bint Jbeil Hospitals: I will Try to Support the Disadvantaged Areas with the Possible Means

 
Tebnine- Minister of Public Health Dr. Jamil Jabak visited this afternoon Tebnine Hospital as part of his tours of governmental hospitals in Marjayoun and Bint Jbeil districts. Jabak was received by MPs Ayoub Hmayyed, Hasan Fadlallah and Ali Bazzi, the chairman of the board of directors of the hospital Dr. Mohamad Hamadeh, the administrative body as well as physicians, Hezbollah official Cheikh Fouad Hanjoul and figures.
 
Jabak visited the hospital’s facilities and heard a briefing by Hamadeh of the equipment and the operations undertaken at the hospital and the large number of patients admitted to the hospital, coming from different regions and villages.

Jabak vowed to exert all possible efforts to provide assistance to the disadvantaged areas within the possible means in collaboration with the parliament and the Health committee.

“I promise to raise the financial ceiling of the governmental hospitals. Our top priority is to improve the quality of services provided by the governmental hospitals and rehabilitate them to admit patients all the month, in particular the uninsured ones,” Jabak added.
Jabak considered also that the salary scale law should apply to the employees and workers of the hospitals.
 
In a statement, Hmayed praised the effective role played by the Minister of Public Health.
 
Jabak and the MPs then visited Bint Jbeil Governmental hospital, where he was received by the chairman of the board of directors, Dr. Toufic Faraj and other figures.
 
“We are committed to provide a pioneering experience in the health care field. We deserve to have the best hospitals. Bint Jbeil Governmental hospital has the best equipment, so why should we transfer the patients to other hospitals or take them to hospitals in Sidon and Beirut?” Fadlallah stated.
 
Jabak visited later Mays al-Jabal Governmental Hospital with MPs Ali Fayyad and Kasem Hachem. He toured its facilities and departments and was informed on its needs in terms of the provision of medical services.
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
C10AX13 REPATHA BioTech Evolocumab - 140mg/1ml Injectable solution 44,151,793 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 179,063,666 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 91,457,321 L.L
L04AB02 REMSIMA SC BioTech Infliximab - 120mg/ml 120mg/ml Injectable solution 52,597,003 L.L
B05BB01 RINGER'S INJECTION USP G Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86% Injectable solution 199,957 L.L
B05BB01 RINGER'S INJECTION, USP G Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l Injectable solution 189,615 L.L
H02AB02 RADOLINE G Dexamethasone sodium phosphate - 8mg/2ml 8mg/2ml Injectable solution 3,711,565 L.L
M03AC09 ROCUCELL G Rocuronium bromide - 50mg/5ml 50mg/5ml Injectable solution 3,633,494 L.L
B05BB01 RINGER'S INJECTION USP G Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86% Injectable solution 129,934 L.L
B05BB01 RINGER'S INJECTION USP G Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86% Injectable solution 205,933 L.L
B05BB01 RINGER'S INJECTION USP G Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86% Injectable solution 224,565 L.L
B05BB01 RINGER'S INJECTION, USP G Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l Injectable solution 204,554 L.L
B05BB01 RINGER'S INJECTION, USP G Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l Injectable solution 154,450 L.L
B05BB01 R-SOL G Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86% Injectable solution 205,933 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID) BioTech Rotavirus bovine-human , live attenuated - Liquid 2,822,069 L.L
C05AE01 RECTOGESIC G Glyceryl trinitrate - 0.2% w/w 0.2% w/w Ointment 2,553,301 L.L
D03AX RENEBO G β-sitosterol - 0.25% w/w 0.25% w/w Ointment 456,906 L.L
D05AX52 ROLIP G Calcipotriol - 50mcg, Betamethasone - 0.5mg Ointment 1,574,983 L.L
M02AA31 ROXONIN TAPE B Loxoprofen Sodium Hydrate - 100mg 100mg Patch 896,343 L.L
M02AA31 ROXONIN TAPE B Loxoprofen Sodium Hydrate - 50mg 50mg Patch 710,893 L.L
V03AE01 RESICAL G Calcium Polystyrene Sulphonate - 93.5% w/w 93.5% Powder 1,292,776 L.L
V03AE01 RESINCALCIO G Calcium Polystyrene Sulphonate - 99.75g/100g 99.75% w/w Powder for suspension 1,673,084 L.L
V03AE01 RESINSODIO G Sodium polystyrene sulphonate - 99.75g/100g 99.75g/100g Powder for suspension 1,534,668 L.L
J01DB05 ROXIL G Cefadroxil (monohydrate) - 250mg/5ml 250mg/5ml Powder for suspension 459,594 L.L
C10AC01 RESINCOLESTIRAMINA G Cholestyramine - 4g 4g Powder for suspension 2,998,113 L.L
R01AB08 RINOFLUIMUCIL B Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125% Solution 419,279 L.L
N05AX08 RISPERDAL B Risperidone - 1mg/ml 1mg/ml Solution 1,377,439 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025